Unicycive Therapeutics
NASDAQ: UNCY
$4.81
as on
Unicycive Therapeutics Stock Performance
as on September 25, 2026 at 2:15 pm IST
Day's Low
Day's High
$4.62$4.86
3.95%
Downside
1.04%
Upside
52 Week's Low
52 Week's High
$3.71$8.7422.87%
Downside
81.70%
Upside
Unicycive Therapeutics share price movements today
- Previous Close
- $4.81
- Open
- $4.81
- Volume
- 873.4K
- Market Cap
- $131.8M
- Day's Low - High
- $4.62 - $4.86
- 52 Week Low - High
- $3.71 - $8.74
Unicycive Therapeutics Historical Returns
- 1 Month Return
- -12.07 %
- 3 Month Return
- -41.41 %
- 1 Year Return
- + 28.61 %
- 3 Year Return
- -21.28 %
- 5 Year Return
- -83.24 %
Unicycive Therapeutics Stock Fundamentals & Key Indicators
Check Unicycive Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$131.8M
EPS (TTM)
-1.674
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.87
Industry PE ratio
-2.69
PEG Ratio
-0.03358503605080483
EBITDA
-34.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-88.81%
Unicycive Therapeutics Stock Valuation
Track how Unicycive Therapeutics P/E has moved over time to understand its valuation trends.
Unicycive Therapeutics in the last 5 years
Lowest (-3.46x)
December 31, 2025
Today (-3.46x)
December 31, 2025
Industry (-2.69x)
December 31, 2025
Highest (-0.45x)
March 31, 2023
Today’s Price to Earnings Ratio: -3.46x
Unicycive Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Unicycive Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $131.8M | -83.24% | -2.87 | 0.00% | 0.00% | |
| Neutral | $72.7B | -54.71% | -22.82 | -12.57% | 0.00% | |
| StrongBuy | $130.9B | 184.51% | 29.81 | 86.04% | 0.00% | |
| Buy | $82.8B | 24.59% | 19.15 | 84.86% | 0.46% |
Stock Returns calculator for Unicycive Therapeutics Stock including INR - Dollar returns
The Unicycive Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Unicycive Therapeutics investment value today
Current value as on today
₹1,38,994
Returns
₹38,994
(+38.99%)
Returns from Unicycive Therapeutics Stock
₹28,610 (+28.61%)
Dollar Impact
₹10,384 (+10.38%)
Analyst Recommendation on Unicycive Therapeutics Stock
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Unicycive Therapeutics. Average target price of $29.6
Unicycive Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Unicycive Therapeutics.
What analysts predicted
83.75%UPSIDE
Target Price
$29.6
Current Price
$4.81
Analyzed by
3 Analysts
Target
$29.60
Unicycive Therapeutics target price $29.6, a slight upside of 83.75% compared to current price of $4.81. According to 3 analysts rating.
Indian Investors' Interest in Unicycive Therapeutics Stock
Search interest for Unicycive Therapeutics Stock has decreased by -28% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Unicycive Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Unicycive Therapeutics Annual Profit & Loss
All numbers in Millions USD
Unicycive Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Unicycive Therapeutics Annual Cash Flow
All numbers in Millions USD
Unicycive Therapeutics News & Key Events
Today's Timeline - 30 June
Tue, 04:35 PM
-Unicycive receives FDA Complete Response Letter for OLC NDA, citing third-party manufacturing deficiencies without new safety or efficacy concerns.
Tue, 08:34 PM
-Unicycive stock falls over 46% following FDA's CRL announcement regarding OLC NDA resubmission.
Insights on Unicycive Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, -14.66M → -1.72M (in $), with an average increase of 329.5% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -271.0K → 568.0K (in $), with an average increase of 147.7% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 98.5% return, outperforming this stock by 119.8%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 663.0%
NEGATIVE IMPACTPrice Dip
In the last 3 months, UNCY stock has moved down by -41.4%
About Unicycive Therapeutics
| Organisation | Unicycive Therapeutics |
| Headquarters | 1975 West El Camino Real, Mountain View, CA, 94040, US |
| Industry | Biotechnology |
| CEO | Shalabh K. Gupta |
| E-voting on shares | Click here to vote |
Key Management of Unicycive Therapeutics
Name | Title |
|---|---|
Dr. Shalabh K. Gupta M.D., MPA | Founder, Chairman, CEO & President |
Dr. Pramod Gupta Ph.D. | Executive Vice President of Pharmaceutical and Business Operations |
Mr. Douglas Jermasek M.B.A. | Executive Vice President of Corporate Strategy |
Mr. John W. Townsend CPA | Chief Financial Officer |
FAQs
What is Unicycive Therapeutics share price today?
Unicycive Therapeutics share price today is $4.81 as on at the close of the market. Unicycive Therapeutics share today touched a day high of $4.86 and a low of $4.62.
What is the 52 week high and 52 week low for Unicycive Therapeutics share?
Unicycive Therapeutics share touched a 52 week high of $8.74 on and a 52 week low of $3.71 on . Unicycive Therapeutics stock price today i.e. is closed at $4.81,which is 44.97% down from its 52 week high and 29.65% up from its 52 week low.
What is Unicycive Therapeutics's market capitalisation today?
Unicycive Therapeutics market capitalisation is $0.00T as on .
How to invest in Unicycive Therapeutics Stock (UNCY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Unicycive Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Unicycive Therapeutics Shares that will get you 0.3119 shares as per Unicycive Therapeutics share price of $4.81 per share as on September 25, 2026 at 8:45 am IST.
What is the minimum amount required to buy Unicycive Therapeutics Stock (UNCY) from India?
Indian investors can start investing in Unicycive Therapeutics (UNCY) shares with as little as ₹95.945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.45 in Unicycive Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Unicycive Therapeutics share’s latest price of $4.81 as on September 25, 2026 at 8:45 am IST, you will get 2.0790 shares of Unicycive Therapeutics. Learn more about
fractional shares .
What are the returns that Unicycive Therapeutics has given to Indian investors in the last 5 years?
Unicycive Therapeutics stock has given -83.24% share price returns and 29.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?